98 related articles for article (PubMed ID: 19089920)
21. Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking.
Scott ME; Ma Y; Farhat S; Shiboski S; Moscicki AB
J Clin Immunol; 2006 May; 26(3):222-32. PubMed ID: 16783462
[TBL] [Abstract][Full Text] [Related]
22. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?
Barton SE; Maddox PH; Jenkins D; Edwards R; Cuzick J; Singer A
Lancet; 1988 Sep; 2(8612):652-4. PubMed ID: 2901519
[TBL] [Abstract][Full Text] [Related]
23. Expression and polimorphism of IFN-gamma gene in patients with cervical cancer.
Kordi Tamandani MK; Sobti RC; Shekari M; Mukesh M; Suri V
Exp Oncol; 2008 Sep; 30(3):224-9. PubMed ID: 18806746
[TBL] [Abstract][Full Text] [Related]
24. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
25. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix.
de Gruijl TD; Bontkes HJ; van den Muysenberg AJ; van Oostveen JW; Stukart MJ; Verheijen RH; van der Vange N; Snijders PJ; Meijer CJ; Walboomers JM; Scheper RJ
Eur J Cancer; 1999 Mar; 35(3):490-7. PubMed ID: 10448305
[TBL] [Abstract][Full Text] [Related]
26. Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia.
Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Buschmann C; Corradini S; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6613-6623. PubMed ID: 36792811
[TBL] [Abstract][Full Text] [Related]
27. Cervical Microbiota Influences Cytokine Diversity in Cervical Intraepithelial Neoplasia among Rural Women in the Akyemansa District of Ghana.
Blay Mensah LB; Ken-Amoah S; Essuman MA; Anane-Fenin B; Agbeno EK; Eliason S; Essien-Baidoo S
Biomed Res Int; 2023; 2023():5129709. PubMed ID: 37635942
[TBL] [Abstract][Full Text] [Related]
28. Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes.
Han D; Leyva CA; Matheson D; Mineo D; Messinger S; Blomberg BB; Hernandez A; Meneghini LF; Allende G; Skyler JS; Alejandro R; Pugliese A; Kenyon NS
Clin Immunol; 2011 Jun; 139(3):290-301. PubMed ID: 21414848
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients.
Abdelhafiz AS; Fouad MA; Sayed-Ahmed MM; Kamel MM; Ali A; Fouda M; Khalil MA; Abdel-Moneim AS; Kamal LM
Virology; 2021 Nov; 563():74-81. PubMed ID: 34478955
[TBL] [Abstract][Full Text] [Related]
30. Nocardia rubra cell-wall skeleton activates an immune response in cervical tissue
Guo Q; Chen W; Sun J; Zhao C; Bai X; Zhang Y; Liu K; Zhang L; Shao S
Front Immunol; 2023; 14():1117545. PubMed ID: 36936958
[No Abstract] [Full Text] [Related]
31. Human Papillomavirus Cervical Infection: Many Ways to a Single Destination.
Gardella B; Pasquali MF; Dominoni M
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679866
[TBL] [Abstract][Full Text] [Related]
32. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
Barillari G; Bei R; Manzari V; Modesti A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948338
[TBL] [Abstract][Full Text] [Related]
33. The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia.
Mitra A; MacIntyre DA; Paraskevaidi M; Moscicki AB; Mahajan V; Smith A; Lee YS; Lyons D; Paraskevaidis E; Marchesi JR; Bennett PR; Kyrgiou M
Genome Med; 2021 Nov; 13(1):176. PubMed ID: 34736529
[TBL] [Abstract][Full Text] [Related]
34. Cervical Cancer: Emerging Immune Landscape and Treatment.
Guo L; Hua K
Onco Targets Ther; 2020; 13():8037-8047. PubMed ID: 32884290
[TBL] [Abstract][Full Text] [Related]
35. Twelve-Year Trend in the Prevalence of High-Risk Human Papillomavirus Infection Among Rwandan Women Living With HIV.
Murenzi G; Kanyabwisha F; Murangwa A; Kubwimana G; Mutesa L; Burk RD; Anastos K; Castle PE
J Infect Dis; 2020 Jun; 222(1):74-81. PubMed ID: 32050023
[TBL] [Abstract][Full Text] [Related]
36. The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis.
Wakabayashi R; Nakahama Y; Nguyen V; Espinoza JL
Microorganisms; 2019 Jul; 7(7):. PubMed ID: 31337018
[TBL] [Abstract][Full Text] [Related]
37. The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer.
Shibata T; Lieblong BJ; Sasagawa T; Nakagawa M
Cancer Treat Rev; 2019 Aug; 78():8-16. PubMed ID: 31302573
[TBL] [Abstract][Full Text] [Related]
38. Molecular Characterization and Biological Function of a Novel LncRNA CRNG in Swine.
Lu Q; Li L; Huang A; Cui L; Zhang Y; Liu Q; Wang X; Wang Y; Liu Z; Yuan Z; Dai M
Front Pharmacol; 2019; 10():539. PubMed ID: 31178726
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
Halec G; Scott ME; Farhat S; Darragh TM; Moscicki AB
Int J Cancer; 2018 Dec; 143(11):2884-2891. PubMed ID: 30121951
[TBL] [Abstract][Full Text] [Related]
40. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
Barros MR; de Oliveira THA; de Melo CML; Venuti A; de Freitas AC
J Immunol Res; 2018; 2018():2912671. PubMed ID: 29854832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
